DIAGNOS INC

Diagnos Inc. (ADK.V) drops 5.13% after a $109K 24‑hr trade, yet its CAD 46M cap and retinal‑image AI platform position it for long‑term upside in health tech.

Diagnos Inc. (ADK.V) gains 1.32% amid market swings; a retinal‑image AI platform that may boost diagnostic accuracy—find out why investors see a short‑term support level.

Diagnos (ADK.V) dips 5% to CAD 0.38 on TSX Venture, trading 60k CAD in 24 hrs. 200‑day SMA at 0.31, 20‑week decline 20.83%. Explore the retinal‑image software firm.

Diagnos Inc. unveils AI‑powered CARA System, boosting retinal diagnostics across Canada with rapid rollout, clinician praise, and faster, more accurate care.